title: Targeting cerebral Bcl-2 expression as a potential therapeutic target in autism: potential usefulness of human recombinant nerve growth factor.
authors.forename: Marianna
authors.initials: M
authors.lastname: Boso
authors.forename: Stefania Ucelli
authors.initials: SU
authors.lastname: di Nemi
authors.forename: Francesco
authors.initials: F
authors.lastname: Barale
authors.forename: Enzo
authors.initials: E
authors.lastname: Emanuele
mesh_terms: D000818:Animals; D001321:Autistic Disorder / Q000188:drug therapy* / Q000235:genetics; D001921:Brain / Q000503:physiopathology; D004195:Disease Models, Animal; D006801:Humans; D020932:Nerve Growth Factor / Q000235:genetics / Q000627:therapeutic use*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000187:drug effects / Q000235:genetics*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D011994:Recombinant Proteins; D020932:Nerve Growth Factor